Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study
Dongfeng Gu, Jiang He, Pamela G. Coxson, et al.
PLoS Medicine (2015) Vol. 12, Iss. 8, pp. e1001860-e1001860
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Global Disparities of Hypertension Prevalence and Control
Katherine T. Mills, Joshua D. Bundy, Tanika N. Kelly, et al.
Circulation (2016) Vol. 134, Iss. 6, pp. 441-450
Open Access | Times Cited: 2951
The global epidemiology of hypertension
Katherine T. Mills, Andrei Ştefănescu, Jiang He
Nature Reviews Nephrology (2020) Vol. 16, Iss. 4, pp. 223-237
Open Access | Times Cited: 2823
Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control
Hana Thomas, Jamie Diamond, Adrianna Vieco, et al.
Global Heart (2018) Vol. 13, Iss. 3, pp. 143-143
Closed Access | Times Cited: 353
Effect of a Community Health Worker–Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina
Jiang He, Vilma Irazola, Katherine T. Mills, et al.
JAMA (2017) Vol. 318, Iss. 11, pp. 1016-1016
Open Access | Times Cited: 186
Age-specific association between blood pressure and vascular and non-vascular chronic diseases in 0·5 million adults in China: a prospective cohort study
Ben Lacey, Sarah Lewington, Robert Clarke, et al.
The Lancet Global Health (2018) Vol. 6, Iss. 6, pp. e641-e649
Open Access | Times Cited: 148
Hypertension and Related Cardiovascular Disease Burden in China
Joshua D. Bundy, Jiang He
Annals of Global Health (2016) Vol. 82, Iss. 2, pp. 227-227
Open Access | Times Cited: 126
Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project
Chao Han, Fangchao Liu, Xueli Yang, et al.
Science China Life Sciences (2018) Vol. 61, Iss. 5, pp. 504-514
Closed Access | Times Cited: 90
Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China
Shijun Xia, Xin Du, Lizhu Guo, et al.
Circulation (2020) Vol. 141, Iss. 7, pp. 530-539
Open Access | Times Cited: 90
The antihypertensive potential of flavonoids from Chinese Herbal Medicine: A review
Yi Cao, Long Xie, Kai Liu, et al.
Pharmacological Research (2021) Vol. 174, pp. 105919-105919
Open Access | Times Cited: 85
Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): a randomized, blinded, crossover trial
Xiexiong Zhao, Tao Liu, Qiong Yang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016
Mark Moses, Paola Pedroza, Ranju Baral, et al.
The Lancet Public Health (2018) Vol. 4, Iss. 1, pp. e49-e73
Open Access | Times Cited: 82
Impact of community based screening for hypertension on blood pressure after two years: regression discontinuity analysis in a national cohort of older adults in China
Simiao Chen, Nikkil Sudharsanan, Feng Huang, et al.
BMJ (2019), pp. l4064-l4064
Open Access | Times Cited: 72
The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
Deliana Kostova, Garrison Spencer, Andrew E. Moran, et al.
BMJ Global Health (2020) Vol. 5, Iss. 9, pp. e002213-e002213
Open Access | Times Cited: 53
Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China
Chen Huang, Andrew E. Moran, Pamela G. Coxson, et al.
Circulation (2017) Vol. 136, Iss. 17, pp. 1575-1584
Open Access | Times Cited: 55
Cost and cost-effectiveness of a school-based education program to reduce salt intake in children and their families in China
Xian Li, Stephen Jan, Lijing L. Yan, et al.
PLoS ONE (2017) Vol. 12, Iss. 9, pp. e0183033-e0183033
Open Access | Times Cited: 51
Primary and secondary prevention interventions for cardiovascular disease in low-income and middle-income countries: a systematic review of economic evaluations
Léopold Ndemnge Aminde, Noah Fongwen, Belén Zapata-Diomedi, et al.
Cost Effectiveness and Resource Allocation (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 50
Use of Cardiovascular Drugs for Primary and Secondary Prevention of Cardiovascular Disease Among Rural-Dwelling Older Chinese Adults
Lin Cong, Yifei Ren, Tingting Hou, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 48
Cost‐Effectiveness of a Multicomponent Primary Care Intervention for Hypertension
Junxing Chay, Tazeen H. Jafar, Rebecca Su, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 8
Open Access | Times Cited: 6
A Systematic Review of Economic Evidence on Community Hypertension Interventions
Donglan Zhang, Guijing Wang, Heesoo Joo
American Journal of Preventive Medicine (2017) Vol. 53, Iss. 6, pp. S121-S130
Open Access | Times Cited: 38
Improving Medication Adherence in Coronary Heart Disease
Leah L. Zullig, Katherine Ramos, Hayden B. Bosworth
Current Cardiology Reports (2017) Vol. 19, Iss. 11
Closed Access | Times Cited: 37
Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study
Miao Wang, Andrew E. Moran, Jing Liu, et al.
PLoS ONE (2016) Vol. 11, Iss. 2, pp. e0146820-e0146820
Open Access | Times Cited: 35
Health economics assessment of statin therapy initiation thresholds for atherosclerosis prevention in China: a cost-effectiveness analysis
Tianyu Feng, Xiaolin Zhang, Jiaying Xu, et al.
International Journal for Equity in Health (2025) Vol. 24, Iss. 1
Open Access
Use of Quadruple Therapy in the Management of Hypertension: A Systematic Review of Randomized Controlled Trials
Khalid AlNemer
Medicina (2025) Vol. 61, Iss. 4, pp. 764-764
Open Access
Cost-Effectiveness of a Comprehensive Approach for Hypertension Control in Low-Income Settings in Argentina: Trial-Based Analysis of the Hypertension Control Program in Argentina
Federico Augustovski, Martín Chaparro, Alfredo Palacios, et al.
Value in Health (2018) Vol. 21, Iss. 12, pp. 1357-1364
Open Access | Times Cited: 31
Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam
Thi-Phuong-Lan Nguyen, E. Pamela Wright, Thanh-Trung Nguyen, et al.
PLoS ONE (2016) Vol. 11, Iss. 5, pp. e0155699-e0155699
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top